HCRS logo
 

Industry


Cardiovascular research, clinical, basic, and transitional, is to a significant degree connected with industry. Industrial laboratories carry out extremely productive research, but also, in a variety of ways, industry reinforces and supports a large number of academic institutions so that they may respond to its needs.

It is, therefore, both reasonable and necessary to include as a main section of this site some of the developments in industry that overlap with our field.

It is easy to see that it would be overoptimistic to attempt to cover more than a small portion of the extremely important developments—scientific, organisational, and commercial—that occur every day in industrial research with a cardiovascular connection.

We do aspire, however, to provide visitors to the site with prompt and accurate information, albeit selective, concerning matters of primary importance.

This main section is divided into subunits that deal with topics useful and essential for those who, like our Society, are active in those areas.

Biotechnology. This branch of technology has extremely wide applications in cardiovascular medicine. Its development in recent years has been very rapid, especially in applications related to fields such as pharmacogenomics, drug production, etc. (For a useful summary see here.) Visitors to this subsection will have the opportunity to link to a number of selected topics (the biotechnology web galaxy) that although dissimilar, can contribute in a variety of ways to the advance of information.

Medical technology. It is easy to see why medical technology, the scientific field that combines science and technology in the the diagnosis and treatment of cardiovascular diseases, ranks highly in the priorities of our Society. We judge that it would beneficial to our members, and more generally to any visitors to the site who are interested in cardiovascular research, to offer a range of links to information concerning the activities of medical technology companies (the medical technology web galaxy).

 

Go to top Top of page


CRF_button

Sign up for our newsletter:

Name:

Email:


Hot Articles


  1. Barreto AD, Alexandrov AV, Lyden P et al. The Argatroban and Tissue-Type Plasminogen Activator Stroke Study: Final Results of a Pilot Safety Study. Stroke 2012;43: 770-775 … more More
  2. Muramatsu T, Matsushita K, Yamashita K et al. Comparison Between Valsartan and Amlodipine Regarding Cardiovascular Morbidity and Mortality in Hypertensive Patients With Glucose Intolerance: NAGOYA HEART Study . Hypertension 2012;59: 580-586 … more More
  3. Belevych AE, Terentyev D, Terentyeva R et al. Shortened Ca2+ Signaling Refractoriness Underlies Cellular Arrhythmogenesis in a Postinfarction Model of Sudden Cardiac Death. Circ. Res. 2012;110: 569-577 … more More
  4. Chatterjee NA, Upadhyay GA, Ellenbogen KA et al. Atrioventricular Nodal Ablation in Atrial Fibrillation: A Meta-Analysis and Systematic Review. Circ Arrhythmia Electrophysiol 2012;5 68-76 … more More
  5. Ekelund U, Luan J, Sherar LB et al. for the International Children's Accelerometry Database (ICAD) Collaborators. Moderate to Vigorous Physical Activity and Sedentary Time and Cardiometabolic Risk Factors in Children and Adolescents JAMA. 2012; 307:704-712 … more More
  6. Maluenda G, Ben-Dor I, Gaglia MA et al. Clinical Outcomes and Treatment After Drug-Eluting Stent Failure: The Absence of Traditional Risk Factors for In-Stent Restenosis. Circ Cardiovasc Interv 2012;5: 12-19 … more More
  7. Held C, Iqbal R, Scott A. Lear SA et al. Physical activity levels, ownership of goods promoting sedentary behaviour and risk of myocardial infarction: results of the INTERHEART study. Eur Heart J 2012; 33: 452-466 … more More
  8. Jamshidi Y, Gibson P, and Ray KK. Undernutrition in adolescence and risk of cardiovascular disease. Eur Heart J 2012 ;33: 433-435 … more More
  9. Coogan PF, White LF, Jerrett M et al. Air Pollution and Incidence of Hypertension and Diabetes Mellitus in Black Women Living in Los Angeles. Circulation 2012;125: 767-772 … more More
  10. Galassi AR, Tomasello SD, Crea F et al. Transient Impairment of Vasomotion Function After Successful Chronic Total Occlusion Recanalization. J Am Coll Cardiol 2012;59 :711-718 … more More